Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic disparities between cancers in adolescent and young adults and in older adults. | Nat Commun | 2022 | 36433963 | PubTator, text mining | PubMed |
| Interaction of Arsenic Exposure and Transcriptomic Profile in Basal Cell Carcinoma. | Cancers (Basel) | 2022 | 36428691 | PubTator, text mining | PubMed |
| Rodent Models of Audiogenic Epilepsy: Genetic Aspects, Advantages, Current Problems and Perspectives. | Biomedicines | 2022 | 36428502 | PubTator, text mining | PubMed |
| The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021. | Front Genet | 2022 | 36425062 | PubTator, text mining | PubMed |
| Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC. | Pharmaceuticals (Basel) | 2022 | 36422541 | PubTator, text mining | PubMed |
| Evolving DNA repair synthetic lethality targets in cancer. | Biosci Rep | 2022 | 36420962 | PubTator, text mining | PubMed |
| Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers. | Front Immunol | 2022 | 36420271 | PubTator, text mining | PubMed |
| Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series. | BMC Res Notes | 2022 | 36419139 | PubTator, text mining | PubMed |
| The role of dietary patterns and erythrocyte membrane fatty acid patterns on mild cognitive impairment. | Front Nutr | 2022 | 36407514 | PubTator, text mining | PubMed |
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2. | Ecancermedicalscience | 2022 | 36405946 | PubTator, text mining | PubMed |
| Integrating transcription factor occupancy with transcriptome-wide association analysis identifies susceptibility genes in human cancers. | Nat Commun | 2022 | 36402776 | PubTator, text mining | PubMed |
| Mono- and biallelic germline variants of DNA glycosylase genes in colon adenomatous polyposis families from two continents. | Front Oncol | 2022 | 36387175 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer. | Front Genet | 2022 | 36386816 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma. | Biomark Res | 2022 | 36376989 | PubTator, text mining | PubMed |
| Interplay between the DNA Damage Response and Immunotherapy Response in Cancer. | Int J Mol Sci | 2022 | 36362142 | PubTator, text mining | PubMed |
| From Processivity to Genome Maintenance: The Many Roles of Sliding Clamps. | Genes (Basel) | 2022 | 36360296 | PubTator, text mining | PubMed |
| Chemoproteomic profiling to identify activity changes and functional inhibitors of DNA-binding proteins. | Cell Chem Biol | 2022 | 36356585 | PubTator, text mining | PubMed |
| Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference samples. | Genome Biol | 2022 | 36352452 | PubTator, text mining | PubMed |
| Molecular Analyses in Peritoneal Metastasis from Colorectal Cancer: A Review-An English Version. | J Anus Rectum Colon | 2022 | 36348949 | PubTator, text mining | PubMed |
| Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36338767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=25